BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center for RNA Biomedicine - ECPv6.15.17//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://rna.umich.edu
X-WR-CALDESC:Events for Center for RNA Biomedicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Detroit
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20210303T160000
DTEND;TZID=America/Detroit:20210303T170000
DTSTAMP:20260427T130741
CREATED:20210126T184444Z
LAST-MODIFIED:20210210T165451Z
UID:7825-1614787200-1614790800@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Melissa J. Moore - Chief Scientific Officer\, Moderna Therapeutics
DESCRIPTION:This event was rescheduled from February 10\, 4:00 pm.\nTo attend on March 3rd\, please register again. Apologies for the inconvenience.  \nZOOM REGISTRATION REQUIRED \n“A timely confluence: The backstory of Moderna’s COVID-19 vaccine”\n \n\nMelissa Moore\, Ph.D.\,\nChief Scientific Officer\, Moderna Therapeutics \nDr. Moore will address scientists and non-scientists\, and will take live questions.  \nFLYER IN PDF \nIn her role as Chief Scientific Officer\, Platform Research\, Dr. Melissa Moore is responsible for leading mRNA biology\, delivery and computation science research at Moderna. She joined Moderna in 2016 from the University of Massachusetts Medical School\, where she served as Professor of Biochemistry & Molecular Pharmacology\, Eleanor Eustis Farrington Chair in Cancer Research and a long-time Investigator at the Howard Hughes Medical Institute (HHMI).  Dr. Moore was also a founding Co-Director of the RNA Therapeutics Institute (RTI) at UMassMed\, and was instrumental in creating the Massachusetts Therapeutic and Entrepreneurship Realization initiative (MassTERi)\, a faculty-led program intended to facilitate the translation of UMMS discoveries into drugs\, products\, technologies and companies.  Dr. Moore is an elected member of the National Academy of Sciences (2017) and a Fellow of the American Academy of Arts and Sciences (2019). \nDr. Moore holds a B.S. in Chemistry and Biology from the College of William and Mary\, and a Ph.D. in Biological Chemistry from MIT\, where she specialized in enzymology under Prof. Christopher T. Walsh.  She began working on RNA metabolism during her postdoctoral training with Phillip A. Sharp at MIT.  During her 23 years as a faculty member\, first at Brandeis and then at UMassMed\, her research encompassed a broad array of topics related to the roles of RNA and RNA-protein (RNP) complexes in gene expression\, and touched on many human diseases including cancer\, neurodegeneration\, and preeclampsia.
URL:https://rna.umich.edu/events/melissa-moore/
CATEGORIES:Seminar
END:VEVENT
END:VCALENDAR